EHNA

From WikiMD.org
Jump to navigation Jump to search

EHNA

EHNA (pronounced: /ˈiːnə/), also known as Erythro-9-(2-Hydroxy-3-nonyl)adenine, is a potent and selective inhibitor of cyclic nucleotide phosphodiesterases (PDEs). It is often used in scientific research to study the role of PDEs in cellular signaling and function.

Etymology

The term "EHNA" is an acronym derived from the chemical name of the compound, Erythro-9-(2-Hydroxy-3-nonyl)adenine.

Related Terms

  • Adenosine: A nucleoside composed of a molecule of adenine attached to a ribose sugar molecule moiety via a β-N9-glycosidic bond.
  • Phosphodiesterase: An enzyme that breaks a phosphodiester bond in DNA or RNA.
  • Cyclic nucleotide: A type of nucleotide that forms a cyclic structure due to a covalent bond between the sugar and phosphate residues.
  • Cellular signaling: A complex system of communication that governs basic cellular activities and coordinates cell actions.

See Also

  • Phosphodiesterase inhibitor: A drug that inhibits one or more phosphodiesterase enzymes.
  • Adenine: One of the two purine nucleobases used in forming nucleotides of the nucleic acids DNA and RNA.
  • Nucleoside: A structural subunit of nucleic acids, the basic genetic material in life forms.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski